Share your insights

Help us by sharing what content you've recieved in your exams


Phobias

Background knowledge 🧠

Definition

  • A phobia is an intense, irrational fear of a specific object, situation, or activity that leads to avoidance behaviour.
  • Classified as an anxiety disorder.
  • Unlike general anxiety disorders, phobias are usually linked to a specific trigger.
  • Can be debilitating if the phobic stimulus is commonly encountered.

Epidemiology

  • Affects approximately 10% of the UK population.
  • More common in females (2:1 ratio compared to males).
  • Onset usually occurs in childhood or adolescence, but can develop at any age.
  • Specific phobias are the most common type.
  • High comorbidity with other anxiety disorders and depression.

Aetiology and Pathophysiology

  • Genetic predisposition: Family history increases risk.
  • Environmental factors: Traumatic experiences linked to the phobic stimulus.
  • Neurobiological factors: Dysregulation in the amygdala and other brain regions involved in fear processing.
  • Cognitive-behavioural theories: Learned responses from negative experiences.
  • Evolutionary theories: Some phobias (e.g., fear of snakes) may have evolutionary survival advantages.

Types

  • Specific phobias: Fear of specific objects or situations (e.g., heights, spiders).
  • Social phobia (Social anxiety disorder): Fear of social situations where one may be judged.
  • Agoraphobia: Fear of situations where escape might be difficult (e.g., open or crowded places).
  • Complex phobias: Involve a deeper psychological impact and include social phobia and agoraphobia.
  • Common phobic stimuli: Animals, natural environments, blood/injections, situational (e.g., flying).

Clinical Features 🌑️

Symptoms

  • Intense fear or anxiety when exposed to the phobic stimulus.
  • Anticipatory anxiety: Fear of encountering the phobic stimulus even when it is not present.
  • Physical symptoms: Palpitations, sweating, trembling, dizziness.
  • Avoidance behaviour: Actively avoiding situations or objects that trigger the phobia.
  • Impaired daily functioning: Severe cases may lead to significant limitations in daily activities.

Signs

  • Visible distress or agitation when discussing or encountering the phobic stimulus.
  • Autonomic arousal: Tachycardia, hyperventilation, sweating.
  • Avoidance of certain places or activities that may expose them to the phobia.
  • May present with somatic symptoms: Headaches, gastrointestinal discomfort.

Investigations πŸ§ͺ

Tests

  • Diagnosis is primarily clinical based on patient history and symptomatology.
  • Use of standardised anxiety scales: e.g., the Fear Questionnaire, Hamilton Anxiety Scale.
  • Consider differential diagnoses: Rule out other anxiety disorders, PTSD, OCD.
  • Assessment for comorbid conditions: Depression, substance misuse.
  • Physical examination if somatic symptoms are severe to exclude other medical conditions.

Management πŸ₯Ό

Management

  • Cognitive Behavioural Therapy (CBT): First-line treatment, particularly exposure therapy.
  • Pharmacotherapy: SSRIs or benzodiazepines for short-term use in severe cases.
  • Supportive therapy: Psychoeducation, relaxation techniques.
  • Lifestyle modifications: Regular exercise, stress management strategies.
  • Consider referral to specialist services for complex phobias or treatment-resistant cases.

Complications

  • Social isolation: Due to avoidance behaviour.
  • Impaired occupational functioning: Inability to attend work or perform job duties.
  • Increased risk of depression and other mental health disorders.
  • Substance misuse: As a coping mechanism.
  • Reduced quality of life: Chronic anxiety and avoidance behaviours.

Prognosis

  • Good prognosis with appropriate treatment, particularly CBT.
  • Early intervention improves outcomes.
  • Chronic course if untreated, with potential worsening of symptoms.
  • Some phobias may resolve spontaneously, especially in children.
  • Ongoing management may be required for complex phobias.

Key Points

  • Phobias are a common and treatable anxiety disorder.
  • Key management is through CBT, particularly exposure therapy.
  • Pharmacotherapy is an adjunct, not first-line, except in severe cases.
  • Early diagnosis and intervention are crucial to prevent complications.
  • Consider underlying causes and comorbidities when assessing patients with phobias.

No comments yet πŸ˜‰

Leave a Reply

General practice